Longevity Peptide Protocols: Anti-Aging Research Stacks for 2026
Research Guide

Longevity Peptide Protocols: Anti-Aging Research Stacks for 2026

The most studied anti-aging peptide combinations — Epithalon, GHK-Cu, and SS-31 protocols for longevity researchers in 2026.

By PeptidesMaxxing Research Team2/10/202612 min read

The Multi-Hallmark Approach to Longevity

The hallmarks of aging framework (Lopez-Otin et al., 2013, updated 2023) identifies 12 interconnected mechanisms of aging. No single compound can address all of them — but combining targeted peptides allows researchers to tackle multiple hallmarks simultaneously.

Protocol 1: The Foundation Stack

Epithalon + GHK-Cu

This foundational combination addresses two fundamental aging mechanisms:

  • **Epithalon:** Telomere elongation via telomerase activation
  • **GHK-Cu:** Gene expression optimization (4,000+ genes) + tissue repair
  • These mechanisms are complementary: Epithalon addresses genomic instability (telomere attrition) while GHK-Cu handles cellular and tissue-level regeneration.

    Protocol 2: The Advanced Longevity Stack

    Epithalon + GHK-Cu + SS-31

    Adding SS-31 addresses the third major hallmark: mitochondrial dysfunction.

  • **Epithalon:** Telomere/genomic stability
  • **GHK-Cu:** Tissue regeneration, anti-inflammation
  • **SS-31:** Mitochondrial function, energy metabolism, ROS reduction
  • This triple combination theoretically addresses the three most tractable hallmarks of aging with current peptide research.

    Protocol 3: The Comprehensive Stack

    Epithalon + GHK-Cu + Thymosin Alpha-1 + Sermorelin

    The most comprehensive longevity stack currently in research:

  • **Epithalon:** Telomere biology
  • **GHK-Cu:** Regeneration + gene expression
  • **Thymosin Alpha-1:** Immune senescence reversal
  • **Sermorelin:** GH axis restoration (declines with age)
  • Research Use Only: All information is for educational and research purposes. Not medical advice. For research use only. Not for human consumption. Consult a qualified physician.